Therapeutic innovation to meet the challenge of rare diseases
All the news from Servier Group
Gaining perspective on therapeutic adherence through a Servier study in cardiology
Servier, buoyed by high-performance R&D, confirms its 2025 trajectory to achieve its 2030 ambition
World Cancer Day: Innovating in oncology to serve patient needs
Servier among the top 3 most innovative oncology companies in France!
Poland, India, and Germany: Our teams mobilized for patients!
Servier and Aitia Announce a New Collaboration Focused on Parkinson’s Disease
Palm Therapeutics wins Servier Discovery Award for its work in the life sciences
Servier committed to energy transition